세계의 초음파 내시경검사(EUS) 시장 예측(-2029년) : 제품별, 유형별, 용도별, 최종사용자별, 지역별

Endoscopic Ultrasonography (EUS) Market by Product (Endoscopes, Ultrasound Processors, Ultrasound Needles, Probes), Type (Diagnostic, Therapeutic), Application (Oncology, GI), End User (Hospitals, Ambulatory Surgical Center) - Global Forecast to 2029

US $ 4,950 ￦ 6,781,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,111,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,166,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 13,701,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

초음파 내시경검사 시장 규모는 예측 기간 중 7.1%의 CAGR로 확대하며, 2024년 13억 7,000만 달러에서 2029년에는 19억 3,000만 달러에 달할 것으로 예측됩니다.

초음파 내시경검사 시장은 암이환율의 상승, 저개발 지역에서 헬스케어 인프라 개발 구상의 증가, 저침습수술에 대한 선호도의 증가, 내시경 시술의 진보 등 많은 요인에 의해 강력한 성장을 달성하고 있습니다.

조사 범위
조사 대상연도	2024-2029년
기준연도	2023년
예측 기간	2024-2029년
검토 단위	금액(달러)
부문	제품별, 유형별, 용도별, 최종사용자별, 지역별
대상 지역	북미, 유럽, 아시아태평양, 중동 및 아프리카(GCC 국가)

예측 기간 중 내시경 부문은 초음파 내시경 검사 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다. 최소침습적 시술에 대한 수요 증가와 정확성과 제어를 강화하는 기술 발전이 중요한 촉진요인으로 작용하고 있습니다. 또한 소화기 질환의 유병률 증가로 인해 보다 효율적이고 정확한 진단 및 치료 절차가 필요해지면서 내시경의 채택이 더욱 증가하고 있습니다. 이러한 요인들은 내시경 시장의 성장 잠재력을 높이고 있습니다.

유형별로는 진단 분야가 초음파 내시경 검사 시장을 주도할 것으로 예상됩니다. 이는 영상 기술의 발전과 함께 만성질환의 조기 및 정확한 발견에 대한 수요가 증가하고 있으며, 실시간 시각화 및 고해상도 영상을 제공하기 때문입니다. 또한 저침습성, 회복 시간 단축, 수술 후 합병증 감소 등의 장점으로 인해 전 세계에서 EUS 유도하 세침흡입술의 채택이 증가하고 있으며, 이는 이 분야의 성장을 더욱 촉진하고 있습니다.

용도별로는 소화기 질환 부문이 초음파 내시경 검사 시장에서 두 번째로 큰 시장 점유율을 차지했습니다. 이러한 높은 점유율은 위암, 만성 췌장염, 췌장암과 같은 소화기 질환의 유병률 증가에 기인합니다. 또한 소화기 질환에 취약한 노년층 인구 증가로 인해 고급 진단 절차에 대한 수요가 증가하고 있습니다. 이러한 요인들은 시장 성장을 가속하는 데 중요한 역할을 하고 있습니다.

최종사용자별로, 초음파 내시경 검사 시장의 병원 부문은 소화기 전문의 및 내시경 전문의와 같은 숙련된 전문가와 함께 광범위한 고급 진단 및 치료 기술을 구성하는 고급 인프라의 가용성과 같은 요인으로 인해 예측 기간 중 가장 큰 점유율을 차지할 것으로 예상됩니다. 예측 기간 중 가장 큰 점유율을 유지할 것으로 예상됩니다. 또한 중요한 헬스케어 센터 역할을 하는 병원들은 진화하는 헬스케어 수요에 대응하기 위해 혁신적인 초음파 내시경 검사 장비에 지속적으로 투자하고 있으며, 이는 시장 성장을 가속하고 있습니다.

세계의 초음파 내시경검사(EUS) 시장에 대해 조사했으며, 제품별, 유형별, 용도별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 개요

제4장 주요 인사이트

제5장 시장 개요

• 서론
• 시장 역학
• 업계 동향
• 밸류체인 분석
• 공급망 분석
• 기술 분석
• Porter's Five Forces 분석
• 주요 이해관계자와 구입 기준
• 규제 분석
• 가격 분석
• 에코시스템 분석
• 특허 분석
• 무역 분석
• 2025-2026년의 주요 컨퍼런스와 이벤트
• 미충족 요구/최종사용자 기대
• AI/생성형 AI가 내시경 초음파 시장에 미치는 영향
• 사례 연구 분석
• 고객 비즈니스에 영향을 미치는 동향/혼란
• 인접 시장
• 투자와 자금조달 시나리오

제6장 초음파 내시경 시장(제품별)

• 서론
• 내시경
• 초음파 프로세서
• 초음파 프로브
• 초음파 바늘
• 액세서리

제7장 내시경적 초음파 시장(유형별)

• 서론
• 진단
• 치료

제8장 내시경적 초음파 시장(용도별)

• 서론
• 종양
• 위장 장애
• 기타

제9장 초음파 내시경 시장(최종사용자별)

• 서론
• 병원
• 외래 수술 센터
• 기타

제10장 내시경적 초음파 시장(지역별)

• 서론
• 북미
  • 북미의 거시경제 전망
  • 미국
  • 캐나다
• 유럽
  • 유럽의 거시경제 전망
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 기타
• 아시아태평양
  • 아시아태평양의 거시경제 전망
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 기타
• 라틴아메리카
  • 라틴아메리카의 거시경제 전망
  • 브라질
  • 멕시코
  • 기타
• 중동 및 아프리카
  • 중동 및 아프리카의 거시경제 전망
  • GCC 국가
  • 기타

제11장 경쟁 구도

• 서론
• 주요 참여 기업의 전략/강점
• 매출 분석, 2019-2023년
• 시장 점유율 분석, 2023년
• 기업 평가 매트릭스 : 주요 참여 기업, 2023년
• 기업 평가 매트릭스 : 스타트업/중소기업, 2023년
• 기업 평가와 재무 지표
• 브랜드/제품 비교
• 주요 기업 R&D평가
• 경쟁 시나리오

제12장 기업 개요

• 주요 참여 기업
  • OLYMPUS CORPORATION
  • MEDTRONIC
  • FUJIFILM HOLDINGS CORPORATION
  • BOSTON SCIENTIFIC CORPORATION
  • PENTAX MEDICAL
  • STERIS
  • CONMED CORPORATION
  • LEPU MEDICAL TECHNOLOGY(BEIJING) CO., LTD.
  • CANON MEDICAL SYSTEMS CORPORATION
  • COOK
• 기타 기업
  • HUACO HEALTHCARE TECHNOLOGIES CO., LTD.
  • SONOSCAPE MEDICAL CORP.
  • ENDOSOUND, INC.
  • LIMACA-MEDICAL
  • BEIJING ZKSK TECHNOLOGY CO., LTD.
  • KAIGEN PHARMA CO., LTD.
  • PIOLAX MEDICAL DEVICES, INC.
  • MICRO-TECH ENDOSCOPY
  • SHAILI ENDOSCOPY
  • ZHEJIANG SOUDON MEDICAL TECHNOLOGY CO., LTD.
  • ENDO-FLEX GMBH
  • ACE MEDICAL DEVICES PVT. LTD.
  • MEDI-GLOBE GMBH
  • MEDORAH MEDITEK PVT. LTD.
  • INNERMEDICAL CO., LTD.

제13장 부록

KSA

영문 목차

영문목차

The endoscopic ultrasonography market is projected to reach USD 1.93 billion by 2029 from USD 1.37 billion in 2024, at a CAGR of 7.1% during the forecast period. The endoscopic ultrasonography market has had strong growth due to a number of factors such as the rising incidences of cancer, growing initiatives to develop healthcare infrastructure in underdeveloped regions, increasing preference for minimally invasive surgeries, and advancements in endoscopic procedures.

Scope of the Report
Years Considered for the Study	2024-2029
Base Year	2023
Forecast Period	2024-2029
Units Considered	Value (USD)
Segments	Product, Type, Application, End User, and Region
Regions covered	North America, Europe, APAC, LATAM, Middle East & Africa (GCC countries)

"By product type, endoscopes segment is expected to account for the largest share in the endoscopic ultrasonography market."

The endoscopes segment accounted for the largest share of the endoscopic ultrasonography market in the forecast period. The increasing demand for minimally invasive procedures, coupled with advancements in technology enhancing precision and control, are significant drivers. Moreover, the rising prevalence of gastrointestinal disorders necessitates more efficient and accurate diagnostic and therapeutic procedures, further boosting the adoption of endoscopes. These factors collectively contribute to the growth potential for this segment within the market.

"Diagnostics segment, by type is expected to have the largest market share in the endoscopic ultrasonography market"

Based on type, the diagnostics segment is expected to dominate the endoscopic ultrasonography market due to the increasing demand for early and accurate detection of chronic diseases coupled with advancements in imaging technology, providing real-time visualization and high-resolution images. Moreover, rising adoption of EUS-guided fine needle aspiration procedures worldwide, driven by their minimally invasive nature and associated benefits like shorter recovery times and reduced post-operative complications have further boosted the growth in this segment, thereby indicating promising growth potential within the endoscopic ultrasonography market.

"The gastrointestinal disorders segment accounted the second-largest market share in the endoscopic ultrasonography market."

By application, the gastrointestinal disorders segment accounted for the second-largest market share in the endoscopic ultrasonography market. This significant share can be attributed to the rising prevalence of gastrointestinal disorders such as gastric cancer, chronic pancreatitis, and pancreatic cancer. Moreover, the growing geriatric population which is more prone to gastrointestinal diseases increasingly demand for advanced diagnostic procedures. These factors' all together play a significant role in propelling market growth.

"Hospitals segment of the endoscopic ultrasonography market is expected to have largest share."

Based on end user, the hospitals segment of the endoscopic ultrasonography market is expected to hold the largest share during the forecast period owing to the factors like the availability of advanced infrastructure constituting broad range of advanced diagnostic and therapeutic techniques, coupled with skilled professionals like gastroenterologists and endoscopists. Moreover, hospitals serving as vital healthcare centers, continuously invest in innovative endoscopic ultrasonography devices to address evolving healthcare demands, thus propelling market growth.

"Asia Pacific to hold third largest market share in the endoscopic ultrasonography market during the forecast period."

The Asia Pacific region accounted the third largest share in the endoscopic ultrasonography market in the forecast period. The growth is attributed to several factors, including the growing advanced healthcare infrastructure, widespread acceptance of innovative medical devices, and increasing healthcare expenditure in Asia Pacific region. Additionally, the ongoing enhancements in endoscopic technologies are anticipated to increase the demand for endoscopic ultrasonography devices in APAC region.

A breakdown of the primary participants (supply side) for the endoscopic ultrasonography market referred to for this report is provided below:

• By Company Type: Tier 1-35%, Tier 2-20%, and Tier 3-45%
• By Designation: C-level-35%, Director Level- 45%, and Others-20%
• By Region: North America-40%, Europe-30%, Asia Pacific-20%, Latin America-5%, and Middle East & Africa-5%

Prominent players in the endoscopic ultrasonography market include Olympus Corporation (Japan), Medtronic (US), FUJIFILM Holdings Corporation (Japan), Boston Scientific Corporation (US), PENTAX Medical (Japan), Steris (Ireland), CONMED Corporation (US), Lepu Medical Technology(Beijing)Co., Ltd. (China), CANON MEDICAL SYSTEMS CORPORATION (Japan), Cook (US), Huaco Healthcare Technologies Co. Ltd.(China), SonoScape Medical Corp.(China), Endosound, Inc.(US), Limaca-Medical (Israel), Beijing ZKSK Technology Co., Ltd. (China), Kaigen Pharma Co., Ltd.(Japan), PIOLAX MEDICAL DEVICES, INC.(Japan), Micro-Tech Endoscopy (US), Shaili Endoscopy (India), Zhejiang Soudon Medical Technology Co., Ltd.(China), ENDO-FLEX GmbH. (Germany), Ace Medical Devices Pvt. Ltd. (India), Medi-Globe GmbH.(Arizona), Medorah Meditek Pvt. Ltd.(India), and InnerMedical Co., Ltd. (China).

Research Coverage:

The report analyzes the endoscopic ultrasonography market and aims at estimating the market size and future growth potential of this market based on various segments such as product, type, application, end user and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall endoscopic ultrasonography market. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

• Analysis of key drivers (increasing requirement for endoscopy procedures to diagnose and treat target diseases, rising incidence of gastrointestinal disorders and colorectal cancer, increased investments, funds, and grants by government bodies and other organizations, technological advancements in endoscopic ultrasonography devices), restraints (high costs of endoscopic ultrasonography procedures, and complications and limitations of endoscopic ultrasonography), opportunities (high market growth potential in emerging economies, and increasing preference for minimally invasive surgeries) and challenges (increasing number of product recalls).
• Market Penetration: It includes extensive information on products offered by the major players in the global the endoscopic ultrasonography market. The report includes various segments in product, type, application, end user and region.
• Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global endoscopic ultrasonography market.
• Market Development: Thorough knowledge and analysis of the profitable rising markets by product, type, application, end user and region.
• Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global the endoscopic ultrasonography market.
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global endoscopic ultrasonography market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION AND GEOGRAPHICAL SPREAD
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key sources of secondary data
    • 2.1.1.2 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key primary sources
    • 2.1.2.2 Key objectives of primary research
    • 2.1.2.3 Key data from primary sources
    • 2.1.2.4 Key primary insights
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
  • 2.2.2 TOP-DOWN APPROACH
  • 2.2.3 DEMAND-SIDE APPROACH
  • 2.2.4 VOLUME DATA ANALYSIS
  • 2.2.5 PROCEDURE DATA ANALYSIS
• 2.3 DATA TRIANGULATION
• 2.4 MARKET SHARE ANALYSIS
• 2.5 STUDY ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ENDOSCOPIC ULTRASOUND MARKET OVERVIEW
• 4.2 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET, BY END USER AND COUNTRY, 2023
• 4.3 ENDOSCOPIC ULTRASOUND MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.4 ENDOSCOPIC ULTRASOUND MARKET: REGIONAL MIX
• 4.5 ENDOSCOPIC ULTRASOUND MARKET: DEVELOPED VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing requirement for endoscopy procedures to diagnose and treat target diseases
    • 5.2.1.2 Rising incidence of gastrointestinal disorders and colorectal cancer
    • 5.2.1.3 Increased investments, funds, and grants by government bodies and other organizations
    • 5.2.1.4 Technological advancements in endoscopic ultrasound devices
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High costs of endoscopic ultrasound procedures
    • 5.2.2.2 Complications and limitations of endoscopic ultrasound
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 High market growth potential in emerging economies
    • 5.2.3.2 Increasing preference for minimally invasive surgeries
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Increasing number of product recalls
• 5.3 INDUSTRY TRENDS
  • 5.3.1 ULTRASOUND CAPSULE ENDOSCOPY
  • 5.3.2 ENDOSCOPIC ULTRASOUND-GUIDED SHEAR WAVE ELASTOGRAPHY
• 5.4 VALUE CHAIN ANALYSIS
• 5.5 SUPPLY CHAIN ANALYSIS
• 5.6 TECHNOLOGY ANALYSIS
  • 5.6.1 KEY TECHNOLOGIES
    • 5.6.1.1 Contrast-enhanced endoscopic ultrasound
    • 5.6.1.2 Lumen-apposing metal stents
  • 5.6.2 COMPLEMENTARY TECHNOLOGIES
    • 5.6.2.1 Elastography
• 5.7 PORTER'S FIVE FORCES ANALYSIS
  • 5.7.1 THREAT OF NEW ENTRANTS
  • 5.7.2 THREAT OF SUBSTITUTES
  • 5.7.3 BARGAINING POWER OF SUPPLIERS
  • 5.7.4 BARGAINING POWER OF BUYERS
  • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.8 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.8.2 KEY BUYING CRITERIA
• 5.9 REGULATORY ANALYSIS
  • 5.9.1 REGULATORY FRAMEWORK
    • 5.9.1.1 North America
      • 5.9.1.1.1 US
      • 5.9.1.1.2 Canada
    • 5.9.1.2 Europe
      • 5.9.1.2.1 Germany
      • 5.9.1.2.2 France
      • 5.9.1.2.3 UK
      • 5.9.1.2.4 Italy
  • 5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.10 PRICING ANALYSIS
  • 5.10.1 AVERAGE SELLING PRICE TREND OF ENDOSCOPIC ULTRASOUND PRODUCTS, BY KEY PLAYER, 2021-2023
  • 5.10.2 AVERAGE SELLING PRICE TREND OF ENDOSCOPIC ULTRASOUND PRODUCTS, BY REGION, 2021-2023
• 5.11 ECOSYSTEM ANALYSIS
  • 5.11.1 ROLE IN ECOSYSTEM
• 5.12 PATENT ANALYSIS
  • 5.12.1 PATENT PUBLICATION TRENDS FOR ENDOSCOPIC ULTRASOUND
  • 5.12.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
• 5.13 TRADE ANALYSIS
  • 5.13.1 IMPORT DATA FOR HS CODE 901890
  • 5.13.2 EXPORT DATA FOR HS CODE 901890
• 5.14 KEY CONFERENCES & EVENTS, 2025-2026
• 5.15 UNMET NEEDS/END-USER EXPECTATIONS
• 5.16 IMPACT OF AI/GEN AI ON ENDOSCOPIC ULTRASOUND MARKET
• 5.17 CASE STUDY ANALYSIS
• 5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
• 5.19 ADJACENT MARKETS
• 5.20 INVESTMENT & FUNDING SCENARIO

6 ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 ENDOSCOPES
  • 6.2.1 RADIAL ENDOSCOPES
    • 6.2.1.1 High image quality, improved penetration depth, and excellent maneuverability to propel segment growth
  • 6.2.2 LINEAR ENDOSCOPES
    • 6.2.2.1 Improved real-time targeting of lesions and better clinical management to aid segment growth
• 6.3 ULTRASOUND PROCESSORS
  • 6.3.1 ULTRASOUND PROCESSORS TO PRECISELY DETECT ABNORMALITIES AND FACILITATE BETTER TREATMENT PLANNING
• 6.4 ULTRASOUND PROBES
  • 6.4.1 CONSTANT INNOVATIONS AND ADVANCEMENTS TO AUGMENT MARKET GROWTH
• 6.5 ULTRASOUND NEEDLES
  • 6.5.1 FINE NEEDLE ASPIRATION
    • 6.5.1.1 Superior accuracy and effectiveness in staging cancer to fuel segment growth
  • 6.5.2 FINE NEEDLE BIOPSIES
    • 6.5.2.1 Improved diagnostic accuracy in pancreatic and non-pancreatic lesions to boost segment growth
  • 6.5.3 OTHER ULTRASOUND NEEDLES
• 6.6 ACCESSORIES
  • 6.6.1 INCREASING ADOPTION OF ACCESSORIES FOR BETTER EFFICIENCY, PRECISION, AND SAFETY OF PROCEDURES TO DRIVE MARKET

7 ENDOSCOPIC ULTRASOUND MARKET, BY TYPE

• 7.1 INTRODUCTION
• 7.2 DIAGNOSTICS
  • 7.2.1 RISING PREVALENCE OF GASTROINTESTINAL DISEASES TO PROPEL MARKET GROWTH
• 7.3 THERAPEUTICS
  • 7.3.1 INCREASING ADOPTION OF MINIMALLY INVASIVE PROCEDURES FOR PANCREATIC DISORDERS TO AID SEGMENT GROWTH

8 ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 ONCOLOGY
  • 8.2.1 UPPER GASTROINTESTINAL ONCOLOGY
    • 8.2.1.1 Increasing incidence of esophageal and gastric cancers to drive segment
  • 8.2.2 LOWER GASTROINTESTINAL ONCOLOGY
    • 8.2.2.1 High prevalence of colorectal cancer to support segment growth
• 8.3 GASTROINTESTINAL DISORDERS
  • 8.3.1 PANCREATIC DISORDERS
    • 8.3.1.1 Rising burden of chronic pancreatic diseases to aid segment growth
  • 8.3.2 OTHER GASTROINTESTINAL DISORDERS
• 8.4 OTHER APPLICATIONS

9 ENDOSCOPIC ULTRASOUND MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 HOSPITALS
  • 9.2.1 INCREASED DEMAND FOR ADVANCED IMAGING TECHNIQUES AND PRECISE DIAGNOSTICS TO SPUR MARKET GROWTH
• 9.3 AMBULATORY SURGERY CENTERS
  • 9.3.1 COST-EFFECTIVENESS AND HIGH REIMBURSEMENT RATES TO PROPEL MARKET GROWTH
• 9.4 OTHER END USERS

10 ENDOSCOPIC ULTRASOUND MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 US to dominate North American endoscopic ultrasound market during forecast period
  • 10.2.3 CANADA
    • 10.2.3.1 Rising incidence of cancer and increasing focus on early disease detection to propel market growth
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 Increased healthcare spending and favorable research initiatives to spur market growth
  • 10.3.3 UK
    • 10.3.3.1 High government healthcare funding to support market growth
  • 10.3.4 FRANCE
    • 10.3.4.1 Advancements in healthcare and favorable national health insurance to fuel market growth
  • 10.3.5 ITALY
    • 10.3.5.1 Rising geriatric population and increasing focus on cancer care to propel market growth
  • 10.3.6 SPAIN
    • 10.3.6.1 High prevalence of lifestyle-related cancer risk and increased healthcare expenditure to augment market growth
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 10.4.2 JAPAN
    • 10.4.2.1 Favorable government health insurance schemes and high geriatric population to aid market growth
  • 10.4.3 CHINA
    • 10.4.3.1 Large patient pool and high obesity rates to drive market
  • 10.4.4 INDIA
    • 10.4.4.1 Increasing prevalence of cancer and improved government healthcare initiatives to aid market growth
  • 10.4.5 SOUTH KOREA
    • 10.4.5.1 High incidence of gastrointestinal diseases and cancer among aged population to fuel market growth
  • 10.4.6 AUSTRALIA
    • 10.4.6.1 Increased patient volume and favorable government initiatives to drive market
  • 10.4.7 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 10.5.2 BRAZIL
    • 10.5.2.1 High risk of chronic diseases among geriatric population to propel market growth
  • 10.5.3 MEXICO
    • 10.5.3.1 Improved healthcare infrastructure and increased cancer awareness to augment market growth
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 10.6.2 GCC COUNTRIES
    • 10.6.2.1 Increasing healthcare infrastructure development and investment to support market growth
  • 10.6.3 REST OF MIDDLE EAST AND AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 INTRODUCTION
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ENDOSCOPIC ULTRASOUND MARKET
• 11.3 REVENUE ANALYSIS, 2019-2023
• 11.4 MARKET SHARE ANALYSIS, 2023
• 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 11.5.1 STARS
  • 11.5.2 EMERGING LEADERS
  • 11.5.3 PERVASIVE PLAYERS
  • 11.5.4 PARTICIPANTS
  • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 11.5.5.1 Company footprint
    • 11.5.5.2 Region footprint
    • 11.5.5.3 Product footprint
    • 11.5.5.4 Type footprint
    • 11.5.5.5 Application footprint
    • 11.5.5.6 End-user footprint
• 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 11.6.1 PROGRESSIVE COMPANIES
  • 11.6.2 RESPONSIVE COMPANIES
  • 11.6.3 DYNAMIC COMPANIES
  • 11.6.4 STARTING BLOCKS
  • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • 11.6.5.1 Detailed list of key startups/SMEs
    • 11.6.5.2 Competitive benchmarking of key startups/SMEs
• 11.7 COMPANY VALUATION & FINANCIAL METRICS
• 11.8 BRAND/PRODUCT COMPARISON
• 11.9 R&D ASSESSMENT OF KEY PLAYERS
• 11.10 COMPETITIVE SCENARIO
  • 11.10.1 PRODUCT LAUNCHES & APPROVALS
  • 11.10.2 EXPANSIONS
  • 11.10.3 DEALS
  • 11.10.4 OTHER DEVELOPMENTS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 OLYMPUS CORPORATION
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Product launches & approvals
      • 12.1.1.3.2 Deals
      • 12.1.1.3.3 Expansions
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Key strengths
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses & competitive threats
  • 12.1.2 MEDTRONIC
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products offered
    • 12.1.2.3 Recent developments
      • 12.1.2.3.1 Product approvals
      • 12.1.2.3.2 Deals
      • 12.1.2.3.3 Expansions
    • 12.1.2.4 MnM view
      • 12.1.2.4.1 Key strengths
      • 12.1.2.4.2 Strategic choices
      • 12.1.2.4.3 Weaknesses & competitive threats
  • 12.1.3 FUJIFILM HOLDINGS CORPORATION
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Product launches & approvals
      • 12.1.3.3.2 Deals
      • 12.1.3.3.3 Other developments
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Key strengths
      • 12.1.3.4.2 Strategic choices
      • 12.1.3.4.3 Weaknesses & competitive threats
  • 12.1.4 BOSTON SCIENTIFIC CORPORATION
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products offered
    • 12.1.4.3 Recent developments
      • 12.1.4.3.1 Product approvals
      • 12.1.4.3.2 Deals
    • 12.1.4.4 MnM view
      • 12.1.4.4.1 Key strengths
      • 12.1.4.4.2 Strategic choices
      • 12.1.4.4.3 Weaknesses & competitive threats
  • 12.1.5 PENTAX MEDICAL
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products offered
    • 12.1.5.3 Recent developments
      • 12.1.5.3.1 Product launches & approvals
      • 12.1.5.3.2 Deals
    • 12.1.5.4 MnM view
      • 12.1.5.4.1 Key strengths
      • 12.1.5.4.2 Strategic choices
      • 12.1.5.4.3 Weaknesses & competitive threats
  • 12.1.6 STERIS
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products offered
    • 12.1.6.3 Recent developments
      • 12.1.6.3.1 Deals
      • 12.1.6.3.2 Expansions
  • 12.1.7 CONMED CORPORATION
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products offered
    • 12.1.7.3 Recent developments
      • 12.1.7.3.1 Deals
  • 12.1.8 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products offered
    • 12.1.8.3 Recent developments
      • 12.1.8.3.1 Product approvals
  • 12.1.9 CANON MEDICAL SYSTEMS CORPORATION
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products offered
    • 12.1.9.3 Recent developments
      • 12.1.9.3.1 Deals
  • 12.1.10 COOK
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products offered
    • 12.1.10.3 Recent developments
      • 12.1.10.3.1 Product launches
      • 12.1.10.3.2 Deals
      • 12.1.10.3.3 Expansions
• 12.2 OTHER PLAYERS
  • 12.2.1 HUACO HEALTHCARE TECHNOLOGIES CO., LTD.
  • 12.2.2 SONOSCAPE MEDICAL CORP.
  • 12.2.3 ENDOSOUND, INC.
  • 12.2.4 LIMACA-MEDICAL
  • 12.2.5 BEIJING ZKSK TECHNOLOGY CO., LTD.
  • 12.2.6 KAIGEN PHARMA CO., LTD.
  • 12.2.7 PIOLAX MEDICAL DEVICES, INC.
  • 12.2.8 MICRO-TECH ENDOSCOPY
  • 12.2.9 SHAILI ENDOSCOPY
  • 12.2.10 ZHEJIANG SOUDON MEDICAL TECHNOLOGY CO., LTD.
  • 12.2.11 ENDO-FLEX GMBH
  • 12.2.12 ACE MEDICAL DEVICES PVT. LTD.
  • 12.2.13 MEDI-GLOBE GMBH
  • 12.2.14 MEDORAH MEDITEK PVT. LTD.
  • 12.2.15 INNERMEDICAL CO., LTD.

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS

관련자료